KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,680 | -70.3% | 30,200 | -52.3% | 0.01% | -64.7% |
| Q3 2022 | $346,000 | +16.5% | 63,328 | -3.9% | 0.02% | +41.7% |
| Q2 2022 | $297,000 | -62.8% | 65,928 | -39.1% | 0.01% | -58.6% |
| Q1 2022 | $799,000 | +505.3% | 108,228 | +757.1% | 0.03% | +480.0% |
| Q1 2021 | $132,000 | -35.0% | 12,627 | +17.7% | 0.01% | -54.5% |
| Q2 2020 | $203,000 | -81.1% | 10,728 | -80.8% | 0.01% | -87.1% |
| Q1 2020 | $1,072,000 | -42.9% | 55,800 | -43.0% | 0.08% | -18.3% |
| Q4 2019 | $1,878,000 | +255.0% | 97,900 | +78.0% | 0.10% | +205.9% |
| Q3 2019 | $529,000 | – | 55,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |